Working with the institutional review board

American Journal of Health-System Pharmacy

Volumn 66, Issue 2, 2009, Pages 176-184

  Byerly, Wesley G ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical studies; Compliance; Ethics; Institutional review boards; Methodology

Indexed keywords

CLINICAL STUDY; FOOD AND DRUG ADMINISTRATION; INFORMED CONSENT; INSTITUTIONAL REVIEW; MEDICAL RESEARCH; METHODOLOGY; POLICY; PRIORITY JOURNAL; RESEARCH ETHICS; REVIEW;

EID: 58449117365     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070066     Document Type: Review

References (25)

1. Nuremberg Military Tribunal. The Nuremberg Code. JAMA. 1996; 276:1691.
2. Department of Health and Human Services. Office for Human Research Protections (OHRP). IRB guidebook. www.hhs.gov/ohrp/irb/irb-guidebook.htm (accessed 2007 Feb 2).
3. World Medical Association. Policy. www.wma.net/e/policy/b3.htm (accessed 2007 Jul 19).
4. Council for International Organizations of Medical Sciences (CIOMS). International Guidelines for Biomedical Research Involving Human Subjects. www.cioms.ch/frame-guidelines-nov-2002.htm (accessed 2007 Jul 19).
5. Levine RJ. Ethics and regulation of clinical research. 2nd ed. Baltimore: Urban & Schwarzenberg; 1986:69-72.
6. Evans ME. Legal background of the institutional review board. In: Greenwald RA, Ryan MK, Mulvihill JE, eds. Human subjects research: a handbook for institutional review boards. New York: Plenum Press; 1982:19-27.
7. University of Virginia Health System. Bad blood: the Tuskegee Syphilis Study. www.healthsystem.virginia.edu/internet/library/historical/medical- history/bad-blood/ (accessed 2007 Jan 5).
8. Department of Health and Human Services. Office for Human Research Protections (OHRP). Belmont Report. www.hhs.gov/ohrp/belmontArchive.html (accessed 2007 Feb 2).
9. Department of Health and Human Services. Office for Human Research Protections (OHRP). Tide 45 parts 45. HHS policy for the protection of human subjects. www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm (accessed 2006 Dec 28).
10. Food and Drug Administration. Tide 21 parts 50. Protection of human subjects. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRsearch.cfm? CFRPart=50 (accessed 2006 Dec 28).
11. Food and Drug Administration. Title 21 parts 56. Institutional review boards. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRsearch.cfm?CFRPart= 56 (accessed 2006 Dec 28).
12. Department of Health and Human Services. Office for Human Research Protections (OHRP). Human subjects regulations decision charts. www.hhs.gov/ohrp/humansubjects/guidance/decisioncharts.htm (accessed 2007 Jan 2).
13. Casarett D, Karlawish JH, Sugarman J. Determining when quality improvement initiatives should be considered research: proposed criteria and potential implications. JAMA. 2000; 283:2275-80.
14. Johnson N. Could federal research regulations apply to MUEs, outcomes assessments, QA/QI activities? Formulary. 2001; 36:213-20.
15. Johnson N, Vermeulen LC, Smith KM. A survey of academic medical centers to distinguish between quality improvement and research activities. Qual Manag Health Care. 2006; 15:215-20.
16. Colt HG, Mulnard RA. Writing an application for a human subjects institutional review board. Chest. 2006; 130:1605-7.
17. Lynn MR, Nelson DK. Common (mis)perceptions about IRB review of human subjects research. Nurs Sci Q. 2005; 18:264-70.
18. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987; 317:141-5.
19. Green SM, Giger AM. A review finds that multicenter studies face substantial challenges but strategies exist to achieve institutional review board approval. J Clin Epidemiol. 2006; 59:784-90.
20. Department of Health and Human Services. Office for Human Research Protections (OHRP). Guidance on the use of expedited review procedures. www.hhs.gov/ohrp/humansubjects/guidance/exprev.htm (accessed 2007 Jan 2).
21. Department of Health and Human Services. Office for Human Research Protections (OHRP). Expedited IRB review - categories. www.hhs.gov/ohrp/ humansubjects/guidance/expedited98.htm (accessed 2007 Jan 2).
22. Department of Health and Human Services. Office for Human Research Protections (OHRP). Guidance on written IRB procedures. www.hhs.gov/ohrp/ humansubjects/guidance/irbgd107.htm (accessed 2007 Jan 18).
23. Department of Health and Human Services. Office for Human Research Protections (OHRP). Guidance on reviewing and reporting unanticipated problems involving risks to subjects or others and adverse events. www.hhs.gov/ohrp/ policy/AdvEvntGuid.htm (accessed 2007 Jan 18).
24. Food and Drug Administration. Guidance for clinical investigators, sponsors, and IRBs; adverse event reporting - improving human subject protection. www.fda.gov/CbER/gdlns/advreport.pdf (accessed 2007 Aug 5).
25. Department of Health and Human Services. Office for Human Research Protections (OHRP). Guidance on continuing review. www.hhs.gov/ohrp/ humansubjects/guidance/contrev0107.htm (accessed 2007 Jan 18).